Table Of Contents
1 Introduction 17
1.1 Objectives Of The Study 17
1.2 Market Definition 17
1.3 Overview Of Asia-Pacific Transradial Access Market 17
1.4 Currency And Pricing 18
1.5 Limitation 18
1.6 Markets Covered 19
2 Market Segmentation 21
2.1 Markets Covered 21
2.2 Geographic Scope 22
2.3 Years Considered For The Study 23
2.4 Currency And Pricing 23
2.5 Research Methodology 24
2.6 Primary Interviews With Key Opinion Leaders 27
2.7 Secondary Sources 28
2.8 Assumptions 28
3 Market Overview 29
3.1 Drivers 31
3.1.1 Increasing Cases Of Obese Patients 31
3.1.2 Rising Number Of Heart Problems 32
3.1.3 Growing Use Of Radial Access In Oncology Field 33
3.1.4 Technological Adavancements 34
3.2 Restraints 35
3.2.1 Product Recalls And Failures 35
3.3 Opportunities 36
3.3.1 Emerging Markets 36
3.4 Challenges 37
3.4.1 Side Effects Of Transradial Access 37
3.4.2 Lack Of Skilled Professsionals 37
4 Executive Summary 38
5 Premium Insights 40
6 Asia-Pacific Transradial Access Market, By Product 49
6.1 Overview 50
6.2 Sheaths And Sheath Introducers 52
6.3 Mircrocatheters 53
6.4 Guidewires 54
6.5 Guiding Catheters 55
6.6 Intermediate Catheters 56
6.7 Accessories 57
7 Asia-Pacific Transradial Access Market, By Application 58
7.1 Overview 59
7.2 Cardiology 61
7.3 Peripheral Vascular 62
7.4 Neurovascular 63
8 Asia-Pacific Transradial Access Market, By Usage 64
8.1 Overview 65
8.2 Drug Administration 67
8.3 Fluid And Nutrition Administration 69
8.4 Diagnostics And Testing 71
8.5 Blood Transfusion 73
9 Asia-Pacific Transradial Access Market, By End User 75
9.1 Overview 76
9.2 Hospital 78
9.3 Clinics 79
9.4 Ambulatory Care Centers 80
9.5 Others 81
10 Asia-Pacific Transradial Access System Market, By Geography 82
10.1 Asia- Pacific 82
10.1.1 Japan 93
10.1.2 China 98
10.1.3 India 103
10.1.4 South Korea 108
10.1.5 Australia 113
10.1.6 Singapore 118
10.1.7 Thailand 123
10.1.8 Malaysia 128
10.1.9 Indonesia 133
10.1.10 Philippines 138
10.1.11 Rest Of Asia-Pacific 143
11 Asia-Pacific Transradial Access Market, Company Landscape 144
11.1 Company Share Analysis; Asia Pacific 144
12 Company Profiles 145
12.1 Cardinal Health 145
12.1.1 Company Overview 145
12.1.2 Revenue Analysis ; Cardinal Health 145
12.1.3 Product Portfolio 146
12.1.4 Recent Developments Recent Developments 147
12.2 Stryker 148
12.2.1 Company Overview 148
12.2.2 Revenue Analysis; Stryker 148
12.2.3 Product Portfolio 149
12.2.4 Recent Developments 149
12.3 Angiodynamics Inc 150
12.3.1 Company Overview 150
12.3.2 Revenue Analysis ; Angiodynamics Inc 150
12.3.3 Product Portfolio 151
12.3.4 Recent Developments 151
12.4 Bd 152
12.4.1 Company Overview 152
12.4.2 Revenue Analysis ; Bd 152
12.4.3 Product Portfolio 153
12.4.4 Recent Developments 153
12.5 Amecath 154
12.5.1 Company Overview 154
12.5.2 Company Snapshot; Amecath 154
12.5.3 Product Portfolio 155
12.5.4 Recent Developments 155
12.6 Boston Scientific Corporation 156
12.6.1 Company Overview 156
12.6.2 Revenue Analysis ; Boston Scientific Corporation 156
12.6.3 Product Portfolio 157
12.6.4 Recent Developments 157
12.7 Edwards Lifesciences Corporation 158
12.7.1 Company Overview 158
12.7.2 Revenue Analysis ; Edwards Lifesciences Corporation 158
12.7.3 Product Portfolio 159
12.7.4 Recent Developments 159
12.8 Medtronic 160
12.8.1 Company Overview 160
12.8.2 Revenue Analysis ; Medtronic 160
12.8.3 Product Portfolio 161
12.8.4 Recent Developments 161
12.9 Merit Medical Systems Inc. 162
12.9.1 Company Overview 162
12.9.2 Revenue Analysis; Merit Medical Systems Inc. 162
12.9.3 Product Portfolio 163
12.9.4 Recent Developments 163
12.10 Nipro Corporation 164
12.10.1 Company Overview 164
12.10.2 Revenue Analysis ; Nipro Corporation 164
12.10.3 Product Portfolio 165
12.10.4 Recent Developments 165
12.11 Oscor Inc 166
12.11.1 Company Overview 166
12.11.2 Company Snapshot; Oscor Inc; 166
12.11.3 Roduct Portfolio 166
12.11.4 Recent Developments 167
12.12 Penumbra 168
12.12.1 Company Overview 168
12.12.2 Revenue Analysis; Penumbra 168
12.12.3 Product Portfolio 169
12.12.4 Recent Developments 169
12.13 Smiths Group Plc 170
12.13.1 Company Overview 170
12.13.2 Revenue Analysis ; Smiths Group Plc 170
12.13.3 Product Portfolio 171
12.13.4 Recent Developments 171
12.14 Teleflex Incorporated 172
12.14.1 Company Overview 172
12.14.2 Revenue Analysis ; Teleflex Incorporated 172
12.14.3 Product Portfolio 173
12.14.4 Recent Developments 173
12.15 Terumo Corporation 174
12.15.1 Company Overview 174
12.15.2 Revenue Analysis ; Terumo Corporation 174
12.15.3 Product Portfolio 175
12.15.4 Recent Developments Recent Developments 176
13 Related Reports 177
?